{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:05:13Z","timestamp":1792789513562,"version":"4.5.0"},"reference-count":55,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Taipei Medical University\u2014Taipei Medical University Hospital","award":["114TMU-TMUH-11"],"award-info":[{"award-number":["114TMU-TMUH-11"]}],"id":[{"id":"https:\/\/ror.org\/03k0md330","id-type":"ROR","asserted-by":"crossref"}]},{"award":["114TMU-TMUH-11"],"award-info":[{"award-number":["114TMU-TMUH-11"]}],"id":[{"id":"https:\/\/ror.org\/03k0md330","id-type":"ROR","asserted-by":"publisher"}]},{"name":"National Science and Technology Council Taiwan","award":["NSTC 112-2314-B-038-079-MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-038-079-MY3"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Science and Technology Council Taiwan","award":["NSTC 113-2314-B-038-070-MY3"],"award-info":[{"award-number":["NSTC 113-2314-B-038-070-MY3"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) is one of the most common malignancies worldwide, and the prognosis of patients with metastatic disease remains poor. Solute carrier proteins participate in diverse cellular processes, yet the biological and clinical relevance of the SLC35D family in CRC remains largely unexplored. This study systematically investigated the expression patterns and clinical significance of SLC35D family members and further evaluated the functional role of SLC35D1 in CRC. Bioinformatic analyses using TCGA and other publicly available datasets and analytical platforms were performed to evaluate the expression patterns and clinical significance of SLC35D family members in CRC. Associations of SLC35D1 expression with patient survival, immune cell infiltration, immune checkpoint markers, and cancer-related transcriptional programs were examined. Loss- and gain-of-function experiments in CRC cells were performed to assess the effects of SLC35D1 on cell proliferation, migration, invasion, and EMT-related phenotypes. SLC35D1 expression was significantly decreased in CRC tissues, SLC35D2 showed a nonsignificant downward trend, and SLC35D3 was significantly increased. Lower SLC35D1 expression was associated with poorer clinical outcomes in the TCGA cohort, although this prognostic association was not reproduced in the independent GSE39582 cohort. Bioinformatic analyses further revealed associations between SLC35D1 expression and immune cell infiltration, immune checkpoint markers, and several cancer-related transcriptional programs. Although the association between SLC35D1 and the EMT-related signature was modest, pathway-enrichment analyses suggested a potential relationship with EMT-related processes. Consistent with these observations, loss- and gain-of-function studies showed that SLC35D1 expression was associated with changes in CRC cell proliferation, migration, invasion, and EMT-related molecular phenotypes. Our findings identify SLC35D1 as an understudied SLC35D family member associated with CRC progression and clinical outcome. Functional studies showed that modulation of SLC35D1 expression was associated with changes in malignant phenotypes in CRC cells, whereas its relationships with EMT-related programs and the tumor immune microenvironment warrant further mechanistic investigation. These findings suggest that SLC35D1 may have prognostic relevance in CRC, although its prognostic value requires further validation in independent clinical cohorts.<\/jats:p>","DOI":"10.3390\/ijms27198517","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:07:54Z","timestamp":1790240874000},"page":"8517","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SLC35D1 Is Associated with Colorectal Cancer Progression, EMT-Related Phenotypes, and Immune Infiltration"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3978-3244","authenticated-orcid":false,"given":"Yu-Jia","family":"Chang","sequence":"first","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Center for Precision Medicine and Translational Cancer Research, Department of Medical Research, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 116079, Taiwan"},{"name":"Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei 116079, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei-Yen","family":"Tsai","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235041, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3530-961X","authenticated-orcid":false,"given":"Crystal Ngofi","family":"Zumbi","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chin","family":"Lee","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1767-1455","authenticated-orcid":false,"given":"G. M. Shazzad Hossain","family":"Prince","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8565-4713","authenticated-orcid":false,"given":"Uyanga","family":"Batzorig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Department of Cellular and Molecular Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 116079, Taiwan"},{"name":"School of Medicine, National Tsing Hua University, Hsinchu 300044, Taiwan"},{"name":"Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 300044, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7275-2661","authenticated-orcid":false,"given":"Po-Li","family":"Wei","sequence":"additional","affiliation":[{"name":"Center for Precision Medicine and Translational Cancer Research, Department of Medical Research, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Taipei Cancer Center, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jfma.2019.08.023","article-title":"Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost","volume":"119","author":"Kuo","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11894-019-0703-8","article-title":"The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management","volume":"21","author":"Onyoh","year":"2019","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/CIA.S109285","article-title":"Colorectal cancer development and advances in screening","volume":"11","author":"Simon","year":"2016","journal-title":"Clin. Interv. Aging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s10620-014-3444-4","article-title":"The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening","volume":"60","author":"Grady","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Johdi, N.A., and Sukor, N.F. (2020). Colorectal Cancer Immunotherapy: Options and Strategies. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01624"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/cncr.32163","article-title":"Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer","volume":"125","author":"Piawah","year":"2019","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ajcp\/aqw209","article-title":"Molecular biomarkers for the evaluation of colorectal cancer: Guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology","volume":"147","author":"Sepulveda","year":"2017","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e9652","DOI":"10.15252\/msb.20209652","article-title":"A substrate-based ontology for human solute carriers","volume":"16","author":"Meixner","year":"2020","journal-title":"Mol. Syst. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.mam.2012.12.007","article-title":"Solute carriers (SLCs) in cancer","volume":"34","author":"Bentz","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1016\/j.febslet.2008.10.016","article-title":"The solute carrier (SLC) complement of the human genome: Phylogenetic classification reveals four major families","volume":"582","author":"Fredriksson","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.csbj.2019.08.002","article-title":"Nucleotide Sugar Transporter SLC35 Family Structure and Function","volume":"17","author":"Hadley","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00424-003-1093-0","article-title":"Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35)","volume":"447","author":"Ishida","year":"2004","journal-title":"Pflug. Arch."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm1655","article-title":"Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human","volume":"13","author":"Hiraoka","year":"2007","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygeno.2004.09.010","article-title":"Identification and characterization of human Golgi nucleotide sugar transporter SLC35D2, a novel member of the SLC35 nucleotide sugar transporter family","volume":"85","author":"Ishida","year":"2005","journal-title":"Genomics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.csbj.2014.05.003","article-title":"Structure and function of nucleotide sugar transporters: Current progress","volume":"10","author":"Hadley","year":"2014","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Li, W., Wu, K., Liu, Y., Yang, Y., Wang, W., Li, X., Zhang, Y., Zhang, Q., Zhou, R., and Tang, H. (2020). Molecular cloning of SLC35D3 and analysis of its role during porcine intramuscular preadipocyte differentiation. BMC Genet., 21.","DOI":"10.1186\/s12863-020-0822-0"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1080\/15548627.2016.1179402","article-title":"SLC35D3 increases autophagic activity in midbrain dopaminergic neurons by enhancing BECN1-ATG14-PIK3C3 complex formation","volume":"12","author":"Wei","year":"2016","journal-title":"Autophagy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"C1187","DOI":"10.1152\/ajpcell.00063.2022","article-title":"Glycosaminoglycans in cancer therapy","volume":"322","author":"Wieboldt","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/febs.14748","article-title":"The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer","volume":"286","author":"Wisowski","year":"2019","journal-title":"FEBS J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.yexcr.2018.07.022","article-title":"An extracellular matrix (ECM) model at high malignant colorectal tumor increases chondroitin sulfate chains to promote epithelial-mesenchymal transition and chemoresistance acquisition","volume":"370","author":"Hoshiba","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: From mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Markowski, A.R., Ustymowicz, K., Markowska, A.J., Roma\u0144czyk, W., and Guzi\u0144ska-Ustymowicz, K. (2023). E-Cadherin Expression Varies Depending on the Location within the Primary Tumor and Is Higher in Colorectal Cancer with Lymphoid Follicles. Cancers, 15.","DOI":"10.3390\/cancers15123260"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1541-7786.MCR-18-0637","article-title":"Nuclear E-cadherin acetylation promotes colorectal tumorigenesis via enhancing \u03b2-catenin activity","volume":"17","author":"Zhao","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: Functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1038\/s41598-020-64356-y","article-title":"Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics","volume":"10","author":"Yu","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/gutjnl-2012-304149","article-title":"Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer","volume":"63","author":"Church","year":"2014","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.apsb.2020.11.018","article-title":"Targeting BMI-1-mediated epithelial-mesenchymal transition to inhibit colorectal cancer liver metastasis","volume":"11","author":"Xu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1158\/1078-0432.CCR-13-3173","article-title":"Molecular pathways: Linking tumor microenvironment to epithelial-mesenchymal transition in metastasis","volume":"21","author":"Jung","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.tips.2019.08.006","article-title":"Advances and Challenges in Rational Drug Design for SLCs","volume":"40","author":"Garibsingh","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bharadwaj, R., Jaiswal, S., de la Cruz, E.E.V., and Thakare, R.P. (2024). Targeting solute carrier transporters (SLCs) as a therapeutic target in different cancers. Diseases, 12.","DOI":"10.3390\/diseases12030063"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"BSR20180268","DOI":"10.1042\/BSR20180268","article-title":"The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer","volume":"39","author":"Li","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.18632\/oncotarget.27486","article-title":"SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism","volume":"11","author":"Santoro","year":"2020","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/biologics4030017","article-title":"Solute Carrier Family 35 (SLC35)\u2014An Overview and Recent Progress","volume":"4","author":"Kamiyama","year":"2024","journal-title":"Biologics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ijc.34718","article-title":"qRT-PCR analysis of CEACAM5, KLK6, SLC35D3, MUC2 and POSTN in colon cancer lymph nodes\u2014An improved method for assessment of tumor stage and prognosis","volume":"154","author":"Lindmark","year":"2024","journal-title":"Int. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.7150\/jca.56730","article-title":"SLC34A2 up-regulation and SLC4A4 down-regulation correlates with invasion, metastasis, and the MAPK signaling pathway in papillary thyroid carcinomas","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Gao, H., Liang, J., Duan, J., Chen, L., Li, H., Zhen, T., Zhang, F., Dong, Y., Shi, H., and Han, A. (2021). A Prognosis Marker SLC2A3 Correlates with EMT and Immune Signature in Colorectal Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.638099"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1002\/ctm2.356","article-title":"Emerging roles of the solute carrier family in pancreatic cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"104193","DOI":"10.1016\/j.isci.2022.104193","article-title":"EMT alterations in the solute carrier landscape uncover SLC22A10\/A15 imposed vulnerabilities in pancreatic cancer","volume":"25","author":"Nayak","year":"2022","journal-title":"iScience"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tcb.2021.08.002","article-title":"Solute carrier transporters: Emerging central players in tumour immunotherapy","volume":"32","author":"Chen","year":"2022","journal-title":"Trends Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molcel.2020.09.006","article-title":"Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy","volume":"80","author":"Wang","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Park, S.J., Yoon, B.-H., Kim, S.-K., and Kim, S.-Y. (2019). GENT2: An updated gene expression database for normal and tumor tissues. BMC Med. Genom., 12.","DOI":"10.1186\/s12920-019-0514-7"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_46","first-page":"100625","article-title":"Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors","volume":"5","year":"2024","journal-title":"Innovation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mizuno, H., Kitada, K., Nakai, K., and Sarai, A. (2009). PrognoScan: A new database for meta-analysis of the prognostic value of genes. BMC Med. Genom., 2.","DOI":"10.1186\/1755-8794-2-18"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: Protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-60761-987-1_18","article-title":"Cytoscape: Software for visualization and analysis of biological networks","volume":"696","author":"Kohl","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","article-title":"CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks","volume":"127","author":"Tang","year":"2015","journal-title":"Biosystems"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8517\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:12:30Z","timestamp":1790683950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":55,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198517"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198517","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}